Price $130.52 |
Market Cap
169.51B
|
Sector Health Care |
Div. Growth
7.40%
|
|
P/E
47.7
|
P/B
3.32
|
P/S
5.67
|
Dividend %
2.00%
|
|
P/CF
-
|
P/FCF
97.6
|
Op. Cash Flow
6.24M
|
FCF
1.3
|
|
Op. Margin
13.90%
|
Net Margin
12.00%
|
ROE
7.10%
|
ROI
4.90%
|
|
ROA
3.80%
|
EPS Growth
-25.00%
|
Current Ratio
2.6
|
Debt/Equity
51.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $29.59 | - | - | 10.52B | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.40 | - | - | 43M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
